These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27216550)
1. Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout Mice. Batatinha HA; Lima EA; Teixeira AA; Souza CO; Biondo LA; Silveira LS; Lira FS; Rosa Neto JC J Cell Physiol; 2017 May; 232(5):1008-1019. PubMed ID: 27216550 [TBL] [Abstract][Full Text] [Related]
2. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice. Diniz TA; de Lima Junior EA; Teixeira AA; Biondo LA; da Rocha LAF; Valadão IC; Silveira LS; Cabral-Santos C; de Souza CO; Rosa Neto JC Life Sci; 2021 Feb; 266():118868. PubMed ID: 33310034 [TBL] [Abstract][Full Text] [Related]
3. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice. Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419 [TBL] [Abstract][Full Text] [Related]
4. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet. Zheng F; Cai Y Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282 [TBL] [Abstract][Full Text] [Related]
5. GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis. Luo X; Shi X; Sun Z; Xiao J; Song H; Lu G; Xu X Biomed Res Int; 2020; 2020():1454396. PubMed ID: 33299856 [TBL] [Abstract][Full Text] [Related]
6. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation. de Souza CO; Teixeira AAS; Biondo LA; Lima Junior EA; Batatinha HAP; Rosa Neto JC J Cell Physiol; 2017 Aug; 232(8):2168-2177. PubMed ID: 27925195 [TBL] [Abstract][Full Text] [Related]
7. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819 [TBL] [Abstract][Full Text] [Related]
8. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
9. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD). Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942 [TBL] [Abstract][Full Text] [Related]
10. Effect of an acute moderate-exercise session on metabolic and inflammatory profile of PPAR-α knockout mice. Silveira LS; Pimentel GD; Souza CO; Biondo LA; Teixeira AAS; Lima EA; Batatinha HAP; Rosa Neto JC; Lira FS Cell Biochem Funct; 2017 Dec; 35(8):510-517. PubMed ID: 29063619 [TBL] [Abstract][Full Text] [Related]
11. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923 [TBL] [Abstract][Full Text] [Related]
12. Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet. Mendes IKS; Matsuura C; Aguila MB; Daleprane JB; Martins MA; Mury WV; Brunini TMC Appl Physiol Nutr Metab; 2018 Jan; 43(1):23-29. PubMed ID: 28834687 [TBL] [Abstract][Full Text] [Related]
13. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695 [TBL] [Abstract][Full Text] [Related]
14. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529 [TBL] [Abstract][Full Text] [Related]
15. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672 [TBL] [Abstract][Full Text] [Related]
16. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice. Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996 [TBL] [Abstract][Full Text] [Related]